CORRECTION OF IMMUNE DISTURBANCES IN CHRONIC CEREBRAL ISCHEMIA
The aim of the study was to determine efficiency of Glutoxim, aimed for correction of immune disorders. The drug was administered to the patients with chronic cerebral ischemia (CCI, Stage I and II) complicated by arterial hypertension. Increased contents of pro- and anti-inflammatory cytokines, IFN...
Enregistré dans:
| Auteurs principaux: | , , , , |
|---|---|
| Format: | article |
| Langue: | RU |
| Publié: |
SPb RAACI
2018
|
| Sujets: | |
| Accès en ligne: | https://doaj.org/article/5c43671e252d4288a5b4d1f3a21fa828 |
| Tags: |
Ajouter un tag
Pas de tags, Soyez le premier à ajouter un tag!
|